Group 1 - Tianzhihang Medical Technology Co., Ltd. experienced a stock price increase of 5.43%, reaching 26.19 CNY per share, with a trading volume of 165 million CNY and a turnover rate of 1.42%, resulting in a total market capitalization of 11.942 billion CNY [1] - The company, established on October 22, 2010, and listed on July 7, 2020, focuses on the research, production, sales, and service of orthopedic surgical navigation robots [1] - The revenue composition of the company includes: orthopedic surgical navigation robots (58.31%), supporting equipment and consumables (23.86%), technical services (16.49%), and other (1.31%) [1] Group 2 - Galaxy Fund holds a significant position in Tianzhihang, with the Galaxy Kangle Stock A fund (519673) owning 467,900 shares, representing 5% of the fund's net value, making it the ninth-largest holding [2] - The Galaxy Kangle Stock A fund has a current size of 141 million CNY and has achieved a year-to-date return of 18.34%, ranking 89 out of 5,569 in its category [2] - The fund manager, Fang Wei, has been in charge for 4 years and 280 days, with the fund's total assets amounting to 576 million CNY, and the best and worst returns during his tenure being 2.42% and -12.24%, respectively [2]
天智航股价涨5.43%,银河基金旗下1只基金重仓,持有46.79万股浮盈赚取63.17万元